Table 2.
Characteristics of patients with thyroid carcinoma in the longitudinal study.
| Parameter | Median [interquartile range] |
|---|---|
| Patients (n) | 319 |
| Visits (n) | 2,309 |
| Follow-up duration (months) | 63 [46, 81] |
| Follow-up intervals (months) | Six over the first 5 years, 12 thereafter, if tumor-free |
| Gender (female/male) | 72/28% |
| Age at initial presentation (years) | 50.1 [41.1, 62.0] |
| Body mass index (kg/m2) | 28.2 [24.3, 31.3] |
| Tumor type | Papillary 69%, follicular 19%, other 12% |
| Tumor stage at initial presentation | pT1 46%, pT2 20%, pT3 12%, pT4 3%, N1 12%, M1 4% |
| Ablative treatment | surgery 100%, plus radioiodine 92.5% |
| Weight adjusted LT4 dose (μg/kg BW/day) | 1.84 [1.62, 2.14] |
| TSH (mIU/l) | 0.07 [0.01, 0.46] |
| FT3 (pmol/l) | 5.15 [4.60, 5.80] |
| FT4 (pmol/l) | 22.3 [19.6, 25.4] |